Better cancer diagnostics

VarCT Diagnostics is engaged in the design and development of novel technology for capturing and analysis of circulating tumor cells of diverse origin, ultimately aiming for methods that will allow early screening and detection of all types of cancer

VarCT Diagnostics at a glance

VarCT DIAGNOSTICS is a privately held biotechnology company founded in Copenhagen, Denmark, 2017 as a subsidiary to VAR2 Pharmaceuticals

The technology is based on groundbreaking discoveries made by researchers at University of Copenhagen, Denmark, in collaboration with partners at University of British Columbia, Canada.

Read more
10 September 2018

VarCT Diagnostics/VAR2 Pharmaceuticals will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business.

16 August 2018
Today a ground-breaking article demonstrating the potential of rVAR2-based isolation of Circulating Tumour Cells for diagnosis of multiple types of cancer was published in Nature Communications. The current methods for CTCs isolation are limited by insufficient specificity and sensitivity, which ha...
14 August 2018

Check out the article about VarCT Diagnostics and VAR2 Pharmaceuticals (in Danish) here


28 May 2018
On Monday 3rd June to Thursday 7th June, Cheif Operating Officer Andreas Linderoth Norlin, will attend the BIO International Convention in Boston, MA. It will be four days of exciting meetings to explore new opportunities for collaborations and partnerships in the field of cancer diagnosti...